CINECA IRIS Institutional Research Information System

MIGLIARDI, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.746
AS - Asia 2.841
EU - Europa 2.436
OC - Oceania 93
SA - Sud America 68
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.598
CN - Cina 1.811
IT - Italia 598
GB - Regno Unito 516
DE - Germania 308
JP - Giappone 292
HK - Hong Kong 172
IN - India 166
FR - Francia 144
CA - Canada 128
IE - Irlanda 112
ES - Italia 102
NL - Olanda 90
SG - Singapore 87
SE - Svezia 86
AU - Australia 71
CH - Svizzera 64
FI - Finlandia 64
KR - Corea 63
PL - Polonia 63
TW - Taiwan 49
UA - Ucraina 49
BE - Belgio 46
BR - Brasile 43
TR - Turchia 34
AT - Austria 33
IL - Israele 33
PT - Portogallo 27
VN - Vietnam 26
NZ - Nuova Zelanda 22
RU - Federazione Russa 22
TH - Thailandia 21
DK - Danimarca 20
CZ - Repubblica Ceca 18
NO - Norvegia 18
MX - Messico 17
CO - Colombia 16
IR - Iran 15
GR - Grecia 12
RO - Romania 12
HU - Ungheria 11
MO - Macao, regione amministrativa speciale della Cina 10
ID - Indonesia 9
MY - Malesia 9
PK - Pakistan 9
SA - Arabia Saudita 8
LB - Libano 6
SK - Slovacchia (Repubblica Slovacca) 6
ZA - Sudafrica 6
PH - Filippine 5
AR - Argentina 4
UZ - Uzbekistan 4
EC - Ecuador 3
EE - Estonia 3
EG - Egitto 3
KH - Cambogia 3
QA - Qatar 3
BG - Bulgaria 2
CL - Cile 2
CU - Cuba 2
JO - Giordania 2
KE - Kenya 2
MK - Macedonia 2
MT - Malta 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
EU - Europa 1
GH - Ghana 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
PR - Porto Rico 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
UG - Uganda 1
Totale 9.200
Salva come PNG Salva come JPEG
Città #
Beijing 352
Ann Arbor 332
Shanghai 269
Chandler 236
Fairfield 204
Cambridge 154
Houston 125
Redwood City 122
Guangzhou 121
Woodbridge 115
Seattle 114
Ashburn 113
Torino 108
Dublin 93
Wilmington 92
Tokyo 88
Nanjing 84
New York 71
Dearborn 60
Central 57
London 57
Los Angeles 57
San Diego 52
San Francisco 50
Boston 46
Wuhan 44
Hangzhou 40
Milan 38
Changsha 37
Singapore 37
Pisa 36
Fremont 35
Chengdu 34
Central District 32
Nyköping 31
Taipei 30
Toronto 30
Jacksonville 28
Paris 28
Chongqing 27
Chicago 26
Rome 26
Warsaw 26
Medford 25
Tianjin 25
Turin 25
Vienna 25
Princeton 24
Zhengzhou 24
Manchester 22
Jinan 21
Villeurbanne 21
Dong Ket 20
Duncan 20
Shenyang 20
Bengaluru 19
Munich 18
Ottawa 18
Boardman 17
Heidelberg 17
Brussels 16
Fuzhou 16
Philadelphia 16
San Jose 16
Bethesda 15
Hong Kong 15
Hyderabad 15
Mumbai 15
Sydney 15
Xian 15
Zurich 15
Barcelona 14
Genoa 14
Lappeenranta 14
Shenzhen 14
Belfast 13
Helsinki 13
Memphis 13
Nanchang 13
Amsterdam 12
Berlin 12
Chennai 12
Krakow 12
Toulouse 12
Brookline 11
Dallas 11
Guiyang 11
Gurgaon 11
Harbin 11
La Jolla 11
Melbourne 11
Montréal 11
Napoli 11
Padova 11
Seoul 11
Somerville 11
Vancouver 11
Ankara 10
Auckland 10
Oslo 10
Totale 4.628
Salva come PNG Salva come JPEG
Nome #
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. 4.718
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 693
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 649
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 605
The genomic landscape of response to EGFR blockade in colorectal cancer 336
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 314
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 301
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 266
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 238
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 220
C-met inhibition blocks bone metastasis development induced by renal cancer stem cells 200
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models 164
Phosphoproteomics of patient-derived xenographs identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer 154
Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas 108
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab 93
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene 83
Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas. 80
Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal. 78
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer 24
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 13
Totale 9.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020719 67 38 40 88 56 100 72 55 69 60 44 30
2020/20211.751 33 102 163 173 156 151 156 137 175 184 141 180
2021/20221.924 185 168 193 209 159 152 168 131 166 122 156 115
2022/20231.454 96 124 87 123 97 191 101 147 152 87 129 120
2023/20242.139 178 157 116 213 169 176 183 200 81 187 243 236
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 9.337